Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus enteral amiodarone in critically ill patients with new-onset atrial fibrillation
2025-521289-88-02Phase 4Authorised
- Sponsor
- Aalborg University Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Pharmacokinetic of amiodarone. Planned start Jun 2025; status: authorised.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2025-521289-88-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521289-88-02.